Earnings History Data for Prime Medicine, Inc. (PRME) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Prime Medicine, Inc.
Prime Medicine Inc. is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies. Prime Medicine Inc. is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | PRME | Prime Medicine, Inc. | 492.00 | -0.44 | -0.43 | 0.00 | Prime Medicine GAAP EPS of -$0.44 misses by $0.01, revenue of $0.21M misses by $5.7M [11/13/2024 3:05 AM] |
4.00 | -0.33 (-7.52%) |
4.25 | -0.07 (-1.62%) |
3.28 - 9.86 | 1,321,576 | 920,000 | 33,877 | ||
| 08-08-2024 | PM | PRME | Prime Medicine, Inc. | 543.00 | -0.46 | -0.40 | 0.00 | Prime Medicine GAAP EPS of -$0.46 misses by $0.05 [8/8/2024 8:52 AM] |
4.33 | -0.07 (-1.48%) |
4.65 | 0.25 (5.68%) |
4.11 - 13.60 | 470,456 | 650,000 | 2,784 | ||
| 10-05-2024 | PM | PRME | Prime Medicine, Inc. | 668.06 | -0.44 | -0.45 | -0.44 | Prime Medicine GAAP EPS of -$0.44 beats by $0.03, revenue of $0.59M misses by $0.32M [5/10/2024 8:06 AM] |
5.63 | -0.09 (-1.57%) |
6.05 | 0.33 (5.77%) |
4.11 - 17.20 | 332,569 | 900,000 | 2,810 | ||
| 01-03-2024 | PM | PRME | Prime Medicine, Inc. | 893.00 | -0.56 | -0.48 | 0.00 | Prime Medicine GAAP EPS of -$2.18 [3/1/2024 10:31 AM] |
8.78 | 0.15 (1.74%) |
8.63 | 0.0 (0.00%) |
5.54 - 17.25 | 514,435 | 1,220,000 | 600 | ||
| 03-11-2023 | AH | PRME | Prime Medicine, Inc. | 625.00 | -0.55 | -0.45 | 0.00 | Prime Medicine GAAP EPS of -$0.55 misses by $0.07 [11/3/2023 4:16 PM] |
7.74 | -0.06 (-0.77%) |
7.83 | 0.03 (0.38%) |
5.54 - 21.73 | 659,306 | 590,000 | 3,310 | ||
|
|
||||||||||||||||||
| 07-08-2023 | AH | PRME | Prime Medicine, Inc. | 1,337 | -0.47 | -0.42 | 0.00 | Prime Medicine GAAP EPS of -$0.47 misses by $0.04 [8/7/2023 5:36 PM] |
12.69 | 0.14 (1.12%) |
12.00 | -0.55 (-4.38%) |
11.07 - 21.73 | 360,384 | 280,000 | 847 | ||
| 11-05-2023 | PM | PRME | Prime Medicine, Inc. | 1,365 | -0.44 | -0.42 | 0.00 | Prime Medicine GAAP EPS of -$0.44 in-line [5/11/2023 11:54 AM] |
12.54 | -1.50 (-10.68%) |
13.61 | -0.43 (-3.06%) |
11.07 - 21.73 | 405,549 | 220,000 | 1,564 | ||
| 09-03-2023 | PM | PRME | Prime Medicine, Inc. | 1,456 | -0.56 | -0.77 | 0.00 | Prime Medicine GAAP EPS of -$0.56 misses by $0.25 [3/9/2023 9:12 AM] |
14.65 | -0.68 (-4.44%) |
0.0 | 0.0 (0.00%) |
14.52 - 21.73 | 224,137 | 170,000 | 0 | ||